The National Institute for Health and Clinical Excellence (NICE) published guidelines on the investigation of patients with chest pain of recent onset. The most prominent change to current protocols is that calcium scoring is proposed as the firstline investigation in patients with an estimated likelihood of coronary artery disease (CAD) of 10-29%, proceeding to multidetector computed tomography coronary angiography (CTCA) if the calcium score is above zero. 1 For patients with 30-60% likelihood of CAD, functional testing is recommended with stress echocardiography, single photon emission computed tomography (SPECT) or cardiac magnetic resonance (CMR). For patients with 61-90% likelihood of CAD or calcium score greater than 400, X-ray invasive coronary angiography is recommended.
The rationale underpinning these recommendations is that cardiac CT is considered an accurate 'rule out' test in patients with low likelihood of CAD given the extensive data confirming excellent prognosis of a zero calcium score in asymptomatic populations, and the excellent negative predictive value of CTCA. 2 Functional tests on the other hand have better diagnostic performance in patients with higher pretest likelihood of CAD than in patients with low likelihood (Bayes theorem).
It is hoped that the guidelines will reduce the high rate of normal coronary arteries at X-ray invasive coronary angiography, which was 39% in a recent ACC National Cardiovascular Data Registry, and is likely to be similar in most NHS Trusts. 3 As exercise tolerance testing is no longer recommended; the guidelines will lead to an increase in referrals for imaging functional tests. The choice of imaging modality has been deliberately left open in the guidelines. Although this choice will often be driven by local availability, there are some differences in the evidence base and diagnostic yield and with the increasing awareness of the risks of ionizing radiation from medical exposure, the cumulative radiation burden of patients in their diagnostic journey, warrants particular consideration.
Until recently, the median radiation dose for CTCA has been as high as 22 mSv, which can equate to an estimated risk of future cancer of 1 in every 270 in 40-year-old women undergoing the test. 4 However, it is now possible to significantly reduce the radiation dose from CTCA by reducing the scan length and the scanning field of view to cover just the heart, electrocardiographically controlled tube current modulation during the cardiac cycle and reduction of the output of computed tomography X-ray tube from 120 kVp to 100 kVp for non-obese patients. The most effective way to lower the radiation dose, suitable in patients with regular heart rates below 60 bpm, is prospective electrocardiogramtriggering, which limits the acquisition to 10% of the cardiac cycle reducing the dose to 2 -4 mSv. 5 This is lower than conventional X-ray invasive coronary angiography, but not the new dual axis rotational coronary angiography which reduces radiation dose and contrast load. Such low radiation doses will however not be achievable in many UK centres without some investment.
The imaging functional tests
SPECT is the most widely used functional test for the detection of myocardial ischaemia and its use is justified by an extensive evidence base with excellent prognostic value, in large scale studies, for patients with a normal SPECT and a mean sensitivity and specificity of 86% and 74% in a NICE technology appraisal. 6 SPECT imaging has a relatively high false-positive rate, although this has improved with electrocardiogram gating which allows for the assessment of normal wall motion in segments with artefacts due to soft tissue attenuation. SPECT is associated with substantial exposure to ionizing radiation. In the largest study investigating the cumulative radiation dose in nearly one million Americans, SPECT represented 22% of the total radiation dose to the cohort with a median dose of 15.6 mSv per scan. 7 In another study investigating the cumulative estimated effective dose in 1097 consecutive patients undergoing SPECT, over a 20-year period, 344 (31%) received a cumulative estimated effective dose from all medical sources of more than 100 mSv. Multiple SPECT were performed in 424 (39%) patients with a cumulative estimated effective dose of 121 mSv. 8 Dobutamine stress echocardiography is relatively easy to set up, inexpensive and is widely available. It evaluates reversible ischaemia by comparing the left ventricular wall motion and thickening, using the 16 segment model, at rest and pharmacological stress. Myocardial contrast echocardiography (MCE), using microbubble contrast agents, is used when the image resolution is suboptimal, with contrast specific imaging and a low mechanical index (MI) which effectively nulls the myocardial tissue but detects the contrast, giving an excellent endocardial border definition in most patients. The use of an infusion of contrast, and a burst of a few frames of high MI, to destroy contrast within the myocardium, can also be used to assess contrast replenishment and hence an analogue of myocardial perfusion. This is usually performed at the end of dobutamine stress echocardiography and provides incremental diagnostic and prognostic value. Myocardial perfusion echocardiography can also be performed with vasodilator stress agents such as adenosine with the advantage of shorter administration time, better tolerability and slower heart rate response that improves the analysis of perfusion defects. Dobutamine stress echocardiography and SPECT have been shown to be equivalent in the detection of CAD in a meta-analysis of eight studies and there is similar prognostic data demonstrating low event rate in patients with a normal dobutamine stress echocardiography. The sensitivity and specificity for dobutamine stress echocardiography, based on aggregate published data, are 83% and 80%, respectively. 9 Myocardial perfusion CMR is more complex and currently mainly available in specialist centres. It evaluates reversible ischaemia by detecting underperfused regions in the left ventricular wall during pharmacological (adenosine) stress when compared to rest perfusion and late gadolinium enhancement images, which reliably detect infarcted myocardium as a hyperenhanced scar. The spatial resolution (2-3 mm) of CMR perfusion is significantly higher than SPECT (5 -10 mm) thus allowing for the detection of subendocardial ischaemia. A recent multicentre study of perfusion CMR (MR-IMPACT n = 234) demonstrated improved detection of CAD over SPECT 10 and a recent meta-analysis of perfusion CMR demonstrated a sensitivity of 89% and a specificity of 80% for the detection of CAD.
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SPECT was specifically recommended for women in the NICE technology appraisal as the diagnostic accuracy of the exercise tolerance testing in women was particularly poor. 8 CMR is an alternative test to SEPCT that avoids exposure to ionising radiation with a recent multicentre study demonstrating high diagnostic accuracy of CMR perfusion imaging in women. 12 CMR can also be used analogous to dobutamine stress echocardiography, for assessment of inducible wall motion abnormalities during dobutamine stress. A comparison between dobutamine stress CMR and dobutamine stress echocardiography demonstrated superiority of CMR at detection of ischaemia in patients with suboptimal echocardiography images. 13 Advances in echocardiography such as Harmonic imaging and MCE, together with advances in CMR and a shift to adenosine perfusion, make an up-to-date comparison between the two imaging modalities a clinical necessity. Small CMR studies have demonstrated a similar prognostic value to SPECT and dobutamine stress echocadiography.
Which imaging modality after CTCA?
The evidence is in favour of using CTCA in patients with low likelihood of CAD in view of the excellent negative predictive value of the test. However, this group of patients mostly consists of relatively young and/or female patients who are the most vulnerable from radiation exposure. It is therefore vital to use all the CTCA dose reduction techniques and if indicated choose subsequent functional tests that do not expose patients to further ionizing radiation, whenever possible. Dobutamine stress echocardiography is already widely available and has a strong evidence base while CMR is rapidly evolving both in terms of availability as well as accuracy and outcome data. In female patients the breast tissue is not just radiosensitive but causes attenuation artefacts in SPECT and hence alternative functional tests should always be considered. Similarly, patients with history of multiple previous radiation based investigations should be considered for non-radiation based functional testing. Finally, patients with non-ST segment elevation myocardial infarcts should be considered for CMR where available as late gadolinium-enhanced CMR will most accurately delineate the partial thickness infarcts and the high spatial resolution of perfusion CMR is more likely to detect the presence of ischaemia in partially infracted myocardium.
Moreover, CTCA is increasingly used in patients with higher likelihood of CAD which is driven by its clinical effectiveness, ease of use, fast acquisition time and low cost. Used in such patients a higher proportion will be found to have moderate or severe CAD. There is a tendency to proceed directly to diagnostic X-ray invasive coronary angiography to confirm the severity of the coronary stenoses, because of its recognized superior spatial and temporal resolution. However, two consecutive anatomical tests are unlikely to be the most effective strategy to manage these patients. Ideally the CTCA should be followed by a functional test to evaluate for the presence of ischaemia. Patients with positive functional tests can be listed for X-ray invasive coronary angiography with view to proceeding to percutaneous coronary intervention. Importantly a proportion of these patients will represent with further chest pain symptoms and will undergo repeat investigations. If SPECT is the functional test in use they will have a significant cumulative radiation dose. 8 This emphasizes the importance of using low radiation dose CTCA techniques and non-radiation-based functional tests, whenever possible, particularly for younger and female patients, to keep their cumulative radiation dose as low as possible.
